Management of patients with acute coronary syndromes in real-world practice in Italy: An outcome research study focused on the use of ANTithRombotic Agents: The MANTRA registry

European Heart Journal: Acute Cardiovascular Care

Volumn 2, Issue 1, 2013, Pages 27-34

  Casella, Gianni ^a   di Pasquale, Giuseppe ^a   Oltrona Visconti, Luigi ^b   Pallotti, Maria Giovanna ^a   Lucci, Donata ^c   Caldarola, Pasquale ^d   Scherillo, Marino ^e   Maggioni, Aldo p ^c  

^a MAGGIORE HOSPITAL   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c ANMCO RESEARCH CENTER   (Italy)

^d San Paolo Hospital   (Italy)

^e AO G Rummo   (Italy)

Author keywords

Acute coronary syndromes; bleeding; outcome research

Indexed keywords

EID: 84990328607     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872612471213     Document Type: Article

References (25)

1. Nabel EG and Braunwald E. A tale of coronary artery disease and myocardial infarction. N Engl J Med 2012; 366: 54–63.
2. Fox KAA, Steg PG, Eagle KA, et al.; for the GRACE Investigators. Decline in rates of death and heart failure in acute coronary syndromes, 1999−2006. J Am Med Assoc 2007; 297: 1892–1900.
3. De Luca L, Casella G, Lettino M, et al. Clinical implications and management of bleeding events in patients with acute coronary syndromes. J Cardiovasc Med 2009; 10: 677–686.
4. Rao SV, O'Grady K, Pieper KS, et al. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol 2005; 96: 1200–1206.
5. Eikelboom JW, Mehta SR, Anand SS, et al. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 2006; 114: 774–782.
6. Steg PG, Huber K, Andreotti F, et al. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J 2011; 32: 1854–1864.
7. Dauerman HL, Rao SV, Resnic FS, et al. Bleeding avoidance strategies. Consensus and controversy. J Am Coll Cardiol 2011; 58: 1–10.
8. Marso SP, Amin AP, House JA, et al. for the National Cardiovascular Data Registry. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. JAMA 2010; 303: 2156–2164.
9. Mehran R, Pocock SJ, Stone GW, et al. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial. Eur Heart J 2009; 30: 1457–1466.
10. Mehran R, Pocock S, Nikolsky E, et al. Impact of bleeding on mortality after percutaneous coronary intervention. Results from a patient-level pooled analysis of the REPLACE-2, ACUITY and HORIZON-Ami trials. J Am Coll Cardiol Intv 2011; 4: 654–664.
11. Subherwal S, Bach RG, Chen AY, et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE bleeding score. Circulation 2009; 119: 1873–1882.
12. Fox KAA, Carruthers K, Steg PG, et al.; for the GRACE Investigators. Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The Global Registry of Acute Coronary Events. Eur Heart J 2010; 31: 667–675.
13. Casella G, Cassin M, Chiarella F, et al.; and BLITZ-3 Investigators. Epidemiology and patterns of care of patients admitted to Italian intensive cardiac care units: the BLITZ-3 registry. J Cardiovasc Med 2010; 11: 450–461.
14. Rao AK, Pratt C, Berke A, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial— phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol 1988; 11: 1–11.
15. Di Chiara A, Chiarella F, Savonitto S, et al.; BLITZ Investigators. Epidemiology of acute myocardial infarction in the Italian CCU network: the BLITZ study. Eur Heart J 2003; 24: 1616–1629.
16. Di Chiara A, Fresco C, Savonitto S, et al.; on behalf of BLITZ-2 Investigators. Epidemiology of non-ST elevation acute coronary syndromes in the Italian cardiology network: the BLITZ-2 study. Eur Heart J 2006; 27: 393–405.
17. Moscucci M, Fox KA, Cannon CP, et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003; 24: 1815–1823.
18. Alexander KP and Peterson ED. Minimizing the risks of anticoagulants and platelet inhibitors. Circulation 2010; 121: 1960–1970.
19. Chase AJ, Fretz EB, Warburton WP, et al. Association of the arterial access site at angioplasty with transfusion and mortality: the MORTAL study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg). Heart 2008; 94: 1019–1025.
20. Casella G, Scorcu G, Cassin M, et al. on behalf of the BLITZ-3 Investigators. Elderly pazienti with acute coronary syndromes admitted to Italian Cardiac Care Units: a BLITZ-3 Registry sub-analysis. J Cardiovasc Med (Hagerstown) 2012; 13: 165–174.
21. Spencer FA, Moscucci M, Granger CB, et al. Does comorbidity account for the excess mortality in patients with major bleedings in acute myocardial infarction? Circulation 2007; 116: 2793–2801.
22. Rao SV, O'Grady K, Pieper KS, et al. A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. J Am Coll Cardiol 2006; 47: 809–816.
23. Collet JP, Montalescot G, Blanchet B, et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation 2004; 110: 2361–2367.
24. Wang T, Xiao L, Alexander KP, et al. Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding. Circulation 2008; 118: 2139–2145.
25. Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium (BARC). Circulation 2011; 123: 2736–2747.